APA

Huang F., Peng J., Cheng W., Zhuang Y., Wang L., Li C., Tang J., Chen W., Li Y. & Zhang S. (20170717). MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. : Digestive diseases and sciences.

Chicago

Huang Feng-Ting, Peng Juan-Fei, Cheng Wen-Jie, Zhuang Yan-Yan, Wang Ling-Yun, Li Chu-Qiang, Tang Jian, Chen Wen-Ying, Li Yuan-Hua and Zhang Shi-Neng. 20170717. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. : Digestive diseases and sciences.

Harvard

Huang F., Peng J., Cheng W., Zhuang Y., Wang L., Li C., Tang J., Chen W., Li Y. and Zhang S. (20170717). MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. : Digestive diseases and sciences.

MLA

Huang Feng-Ting, Peng Juan-Fei, Cheng Wen-Jie, Zhuang Yan-Yan, Wang Ling-Yun, Li Chu-Qiang, Tang Jian, Chen Wen-Ying, Li Yuan-Hua and Zhang Shi-Neng. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. : Digestive diseases and sciences. 20170717.